High physical activity and ovarian reserve: a prospective study of normo-ovulatory professional athletes.

Anti-Mullerian hormone Antral follicle count Athletes Follicle stimulating hormone High physical activity Ovarian reserve

Journal

Journal of ovarian research
ISSN: 1757-2215
Titre abrégé: J Ovarian Res
Pays: England
ID NLM: 101474849

Informations de publication

Date de publication:
16 Sep 2022
Historique:
received: 12 06 2022
accepted: 26 08 2022
entrez: 16 9 2022
pubmed: 17 9 2022
medline: 21 9 2022
Statut: epublish

Résumé

This study investigated whether high physical activity affects ovarian reserve in normo-ovulatory, reproductive-age women. This prospective, observational study compared 31 professional female athletes, with 31 women who did not engage in physical activity. It was conducted 2017-2020 in a tertiary medical center. Normo-ovulatory, professional athletes, ages 20-35 years were recruited from The Wingate Institute-the Israeli National Institute for Sport Excellence. They had high International Physical Activity Questionnaire (IPAQ) scores. Non-physically active women, matched by age and body mass index, were recruited from hospital staff. Women were evaluated for ovarian reserve markers on day 2-5 of the menstrual cycle, including follicular stimulating hormone, antral follicle count, anti-Mullerian hormone and Inhibin B. The average age of the high physical activity group was 29.9 ± 4.2 years and the nonactive group 31.6 ± 4.2 years (p = 0.062). Body mass index of both groups were similar (22.5 ± 5.0 vs. 21.4 ± 2.5, respectively; p = 0.1). No differences were observed with respect to follicle stimulating hormone (p = 0.12) and anti-Mullerian hormone (p = 0.16). A trend towards higher total antral follicle count in the high physical activity group vs. the non-active group (34.5 ± 12.9 vs. 28.1 ± 15.2, p = 0.08) and lower Inhibin B (68.1 ± 36.8 vs. 89.4 ± 46.1, p = 0.05). Menarche age correlated with anti-Mullerian hormone (r = 0.387, p = 0.003), as did total antral follicle count (r = 0.368, p = 0.004). IPAQ scores and basal follicle stimulating hormone levels were negatively correlated (r = - 0.292, p = 0.005). Athletic, normo-ovulatory women have ovarian reserves that are at least as good as those of the general population. As this is the first study examining this issue, it could cautiously reassure women engaged in high physical activity regarding ovarian reserve.

Sections du résumé

BACKGROUND BACKGROUND
This study investigated whether high physical activity affects ovarian reserve in normo-ovulatory, reproductive-age women.
METHODS METHODS
This prospective, observational study compared 31 professional female athletes, with 31 women who did not engage in physical activity. It was conducted 2017-2020 in a tertiary medical center. Normo-ovulatory, professional athletes, ages 20-35 years were recruited from The Wingate Institute-the Israeli National Institute for Sport Excellence. They had high International Physical Activity Questionnaire (IPAQ) scores. Non-physically active women, matched by age and body mass index, were recruited from hospital staff. Women were evaluated for ovarian reserve markers on day 2-5 of the menstrual cycle, including follicular stimulating hormone, antral follicle count, anti-Mullerian hormone and Inhibin B.
RESULTS RESULTS
The average age of the high physical activity group was 29.9 ± 4.2 years and the nonactive group 31.6 ± 4.2 years (p = 0.062). Body mass index of both groups were similar (22.5 ± 5.0 vs. 21.4 ± 2.5, respectively; p = 0.1). No differences were observed with respect to follicle stimulating hormone (p = 0.12) and anti-Mullerian hormone (p = 0.16). A trend towards higher total antral follicle count in the high physical activity group vs. the non-active group (34.5 ± 12.9 vs. 28.1 ± 15.2, p = 0.08) and lower Inhibin B (68.1 ± 36.8 vs. 89.4 ± 46.1, p = 0.05). Menarche age correlated with anti-Mullerian hormone (r = 0.387, p = 0.003), as did total antral follicle count (r = 0.368, p = 0.004). IPAQ scores and basal follicle stimulating hormone levels were negatively correlated (r = - 0.292, p = 0.005).
CONCLUSIONS CONCLUSIONS
Athletic, normo-ovulatory women have ovarian reserves that are at least as good as those of the general population. As this is the first study examining this issue, it could cautiously reassure women engaged in high physical activity regarding ovarian reserve.

Identifiants

pubmed: 36114550
doi: 10.1186/s13048-022-01040-x
pii: 10.1186/s13048-022-01040-x
pmc: PMC9482187
doi:

Substances chimiques

Anti-Mullerian Hormone 80497-65-0
Follicle Stimulating Hormone 9002-68-0

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

107

Informations de copyright

© 2022. The Author(s).

Références

Fertil Steril. 2013 Oct;100(4):1039-43
pubmed: 23809497
Aust N Z J Obstet Gynaecol. 2010 Feb;50(1):8-20
pubmed: 20218991
Fertil Steril. 2017 Apr;107(4):1012-1022.e2
pubmed: 28366409
J Clin Endocrinol Metab. 2003 Dec;88(12):5957-62
pubmed: 14671196
Hum Reprod. 2009 Apr;24(4):867-75
pubmed: 19136673
Fertil Steril. 2002 Jan;77(1):141-6
pubmed: 11779604
Fertil Steril. 2009 Mar;91(3):705-14
pubmed: 18321493
Reprod Sci. 2016 Aug;23(8):1019-27
pubmed: 26763552
Hum Reprod. 2018 Jul 1;33(7):1291-1298
pubmed: 29648647
Menopause. 2008 Sep-Oct;15(5):857-61
pubmed: 18427357
J Clin Endocrinol Metab. 2013 May;98(5):2106-15
pubmed: 23533229
Obstet Gynecol. 2007 Nov;110(5):1050-8
pubmed: 17978119
PLoS One. 2013 May 31;8(5):e64510
pubmed: 23762215
Obstet Gynecol Clin North Am. 2012 Dec;39(4):479-93
pubmed: 23182555
J Endocrinol. 2001 Jul;170(1):3-11
pubmed: 11431132
Hum Reprod. 2003 Apr;18(4):700-6
pubmed: 12660259
J Appl Physiol (1985). 1990 Aug;69(2):407-18
pubmed: 2228848
Epidemiology. 2002 Mar;13(2):184-90
pubmed: 11880759
Fertil Steril. 1981 Aug;36(2):183-7
pubmed: 6455305
Hum Reprod Update. 2006 Nov-Dec;12(6):685-718
pubmed: 16891297
J Anim Sci. 2012 Nov;90(11):3770-7
pubmed: 22665656
Med Sci Sports Exerc. 2003 Aug;35(8):1381-95
pubmed: 12900694
Hum Reprod. 2000 Sep;15(9):1937-42
pubmed: 10966990
J Clin Endocrinol Metab. 2008 Sep;93(9):3478-83
pubmed: 18593767
J Clin Endocrinol Metab. 1989 Feb;68(2):402-11
pubmed: 2537332
Fertil Steril. 2002 Feb;77(2):328-36
pubmed: 11821092
Reprod Biomed Online. 2009 May;18(5):717-34
pubmed: 19549453
Hum Reprod Update. 2004 May-Jun;10(3):267-80
pubmed: 15140873
Fertil Steril. 2004 Nov;82(5):1323-9
pubmed: 15533354
J Clin Endocrinol Metab. 1980 Nov;51(5):1150-7
pubmed: 6775000
J Hum Reprod Sci. 2017 Jan-Mar;10(1):44-48
pubmed: 28479755
Fertil Steril. 2011 Jun 30;95(8):2718-21
pubmed: 21704216
Hum Reprod. 2014 Jun;29(6):1117-21
pubmed: 24770999
Br J Sports Med. 2020 Dec;54(24):1451-1462
pubmed: 33239350
Fertil Steril. 2012 Nov;98(5):1097-102
pubmed: 22921077
Hum Reprod. 2005 Jul;20(7):1820-6
pubmed: 15802325
Reprod Biomed Online. 2010 Feb;20(2):274-9
pubmed: 20113966
Fertil Steril. 2019 Oct;112(4 Suppl1):e183-e188
pubmed: 31623731
Fertil Steril. 2007 Jan;87(1):101-6
pubmed: 17109858
Mol Cell Endocrinol. 2010 Mar 25;316(2):172-9
pubmed: 19818376
Fertil Steril. 2011 Jun;95(7):2359-63, 2363.e1
pubmed: 21457958

Auteurs

Netanella Miller (N)

IVF Unit, Department of Obstetrics and Gynecology, Meir Medical Center, 59 Tshernichovsky St., Kfar Saba, Israel. millerne@me.com.
Sackler School of Medicine, Tel Aviv University, Tel Aviv-Yafo, Israel. millerne@me.com.

Yael Pasternak (Y)

Laniado Hospital, Netanyia, Israel.
The Adelson School of Medicine, Ariel University, Ariel, Israel.

Einat Haikin Herzberger (EH)

IVF Unit, Department of Obstetrics and Gynecology, Meir Medical Center, 59 Tshernichovsky St., Kfar Saba, Israel.
Sackler School of Medicine, Tel Aviv University, Tel Aviv-Yafo, Israel.

Hadar Gluska (H)

IVF Unit, Department of Obstetrics and Gynecology, Meir Medical Center, 59 Tshernichovsky St., Kfar Saba, Israel.
Sackler School of Medicine, Tel Aviv University, Tel Aviv-Yafo, Israel.

Chen Dorenstein (C)

Sackler School of Medicine, Tel Aviv University, Tel Aviv-Yafo, Israel.

Roni Rahav (R)

IVF Unit, Department of Obstetrics and Gynecology, Meir Medical Center, 59 Tshernichovsky St., Kfar Saba, Israel.
Sackler School of Medicine, Tel Aviv University, Tel Aviv-Yafo, Israel.

Rina Hemi (R)

Division of Endocrinology, Diabetes and Metabolism, Sheba Medical Center, Ramat Gan, Israel.

Nahid Zada (N)

Division of Endocrinology, Diabetes and Metabolism, Sheba Medical Center, Ramat Gan, Israel.

Amir Wiser (A)

IVF Unit, Department of Obstetrics and Gynecology, Meir Medical Center, 59 Tshernichovsky St., Kfar Saba, Israel.
Sackler School of Medicine, Tel Aviv University, Tel Aviv-Yafo, Israel.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH